Back to results
US 10,370,726 B2Granted
Detecting colorectal neoplasia
AssigneeMayo Foundation for Medical Education and Research
InventorsDavid A. Ahlquist, William R. Taylor, John B. Kisiel, Tracy C. Yab, Douglas W. Mahoney
Life of this patent
Estimating the term…
Abstract
Provided herein is technology for colorectal neoplasia screening and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of colorectal neoplasia in 1) individuals at, older or younger than 50 years of age, or 2) individuals having Lynch Syndrome.
Claims5
A method comprising:
- extracting genomic DNA from a biological sample of a human individual suspected of having or having colorectal neoplasia, wherein the biological sample is a stool sample, a plasma sample, or a blood sample,
- treating the extracted genomic DNA with bisulfite,
- amplifying the bisulfite-treated genomic DNA using primers specific for nine or fewer DNA markers at least including primers specific for USP44, primers specific for OPLAH, and primers specific for LRRC4,
- measuring the methylation level of the CpG site for the nine or fewer DNA markers at least including USP44, OPLAH, and LRRC4 by methylation-specific PCR, quantitative methylation-specific PCR, methylation-sensitive DNA restriction enzyme analysis, or bisulfite genomic sequencing PCR.
1 more element
Dependencies are inferred from the claim text.